Publication
Title
Cytomegalovirus seropositivity is associated with herpes zoster
Author
Abstract
Background Herpes zoster (HZ) is caused by VZV reactivation that is facilitated by a declined immunity against varicella-zoster virus (VZV), but also occurs in immunocompetent individuals. Cytomegalovirus (CMV) infection is associated with immunosenescence meaning that VZV-specific T-cells could be less responsive. Objectives This study aimed to determine whether CMV infection could be a risk factor for the development of HZ. Study design CMV IgG serostatus was determined in stored serum samples from previously prospectively recruited ambulatory adult HZ patients in the UK (N = 223) in order to compare the results with those from UK population samples (N = 1545) by means of a logistic regression (controlling for age and gender). Furthermore, we compared the UK population CMV seroprevalence with those from population samples from other countries (from Belgium (N1 = 1741, N2 = 576), USA (N = 5572) and Australia (N = 2080)). Furthermore, CMV IgG titers could be compared between UK HZ patients and Belgium N2 population samples because the same experimental set-up for analysis was used. Results We found UK ambulatory HZ patients to have a higher CMV seroprevalence than UK population samples (OR 1.56 [1.11 2.19]). CMV IgG seropositivity was a significant risk factor for HZ in the UK (OR 3.06 [1.32 7.04]. Furthermore, high CMV IgG titers (exceeding the upper threshold) were less abundant in CMV-seropositive Belgian N2 population samples than in CMV-seropositive UK HZ patients (OR 0.51 [0.31 0.82]. We found CMV-seroprevalence to increase faster with age in the UK than in other countries (P < 0.05). Conclusions We conclude that CMV IgG seropositivity is associated with HZ. This finding could add to the growing list of risk factors for HZ.
Language
English
Source (journal)
Human vaccines & immunotherapeutics. - Philadelphia, Pa, 2012, currens
Publication
Philadelphia, Pa : 2015
ISSN
2164-5515 [print]
2164-554X [online]
DOI
10.1080/21645515.2015.1037999
Volume/pages
11 :6 (2015) , p. 1394-1399
ISI
000356426800026
Pubmed ID
25905443
Full text (Publisher's DOI)
UAntwerpen
Faculty/Department
Research group
Project info
Quantification of varicella-zoster virus boosting mechanisms with their public health implications for vaccination.
Publication type
Subject
Affiliation
Publications with a UAntwerp address
External links
Web of Science
Record
Identifier
Creation 04.05.2015
Last edited 04.03.2024
To cite this reference